abstract |
The present invention relates to novel compounds and pharmaceutical compositions comprising compounds of the present invention useful as modulators of Rho-related protein kinase (ROCK), for example, ROCK1 and/or ROCK2 inhibitors. Methods of treatment using the compounds are also contemplated by the present invention. The compounds of the present invention are useful for treating ROCK mediated diseases. |